Бериате

Бериате is a human coagulation factor VIII medication used to manage bleeding disorders like hemophilia A. This intravenous therapy helps control and prevent bleeding episodes by replacing missing clotting factors. Suitable for patients requiring factor VIII replacement.

Бериате is primarily used to treat and prevent bleeding episodes in patients with hemophilia A, a genetic disorder causing insufficient clotting factor VIII. It may also be used before surgery or dental procedures to reduce bleeding risk. The medication works by temporarily restoring normal clotting function in the bloodstream.

When administered, Бериате helps the blood clot more effectively, reducing prolonged bleeding during injuries or medical procedures. Patients may experience improved clotting stability over time with regular use. Some users report reduced frequency of bleeding episodes after consistent treatment.

Store Бериате in a refrigerator at 2°C to 8°C (36°F to 46°F) and protect it from light. Do not freeze or shake the vial. Always check the product for particles or discoloration before use. Follow healthcare provider instructions for proper reconstitution and administration to ensure safety.

No known direct drug interactions are reported with Бериате. However, patients should inform their healthcare provider about all medications, including over-the-counter drugs and supplements. Avoid mixing with other intravenous solutions unless directed by a medical professional.